Anti-TIM3 induced global changes in the immune response within the glioma, as reflected by increases in the phagocytic MG, cDC2, CD8 cytotoxic, inflammatory MG, CD4 Tcm, and monocyte populations. This evidence concerns the gene CD8A and central nervous system cancer.